# US FDA approves new radioactive agent for Alzheimer’s brain scans

2026-08-14T23:05:56+00:00 | Health & Science | Indian Opinion Desk

Corroboration: 1 independent outlet

The US Food and Drug Administration has approved Tauklarify, a radioactive agent from Lantheus Holdings, for use in PET scans to help assess patients for Alzheimer's disease. The agent makes abnormal deposits of tau proteins visible in brain images of adults with cognitive impairment. The approval was supported by two studies in which independent readers assessed Tauklarify PET scans from over 500 participants. More than 7 million people in the US have Alzheimer's, a number that could exceed 13 million by 2050, Lantheus said. The tau-imaging market is dominated by Eli Lilly's Tauvid, approved in 2020.

## Coverage

- economictimes.indiatimes.com <https://economictimes.indiatimes.com/news/international/us/in-2020-alzheimers-diagnose-process-received-major-breakthrough-approval-six-years-later-7-million-patient-in-u-s-get-another-big-announcement-for-progressive-brain-disease-treatment/articleshow/133247387.cms>

Tags: Alzheimer’s disease, Eli Lilly, FDA, Lantheus Holdings
Canonical: https://indianopinion.org/us-fda-approves-new-radioactive-agent-for-alzheimers-brain-scans/
License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources.
Cite: https://indianopinion.org/us-fda-approves-new-radioactive-agent-for-alzheimers-brain-scans/#story-in-brief

Review state: restored archive article, accurate at time of publication, not offered to search indexes.